FIGURE 2.
Proportion of patients in remission (HBI score of ≤4 points) over the course of PRECiSE 4 analysis groups defined by previous exposure to certolizumab pegol in the qualifying studies for observed cases (A) and using the NRI analysis (B).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.